Orphazyme makes changes to board of directors

Andrew Mercieca will be proposed as member of the Board of Directors at Orphazyme in April following Thursday's announcement that Catherine Moukheibir will step down from her position.
Photo: Orphazyme/PR
Photo: Orphazyme/PR
by marketwire, translated by daniel pedersen

Orphazyme has appointed Andrew Mercieca as observer and consultant to the board, intending to formally appoint him member at the company's annual general meeting in April, it reports in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading